Research
ISCHEMIC STROKE CLINICAL TRIAL
Every year in the United States alone, almost 800,000 people suffer a stroke. Of that number, more than 137,000 will die from a stroke, making it the third highest cause of death in the United States. Stemedica Cell Technologies, Inc. is sponsoring a clinical trial using adult bone-marrow derived mesenchymal stem cells for ischemic stroke patients who had their stroke no less than six months ago.
The clinical trial is conducted at the University of California, San Diego with Michael Levy, M.D. as the principal investigator. To learn more about the trial, please see the information below, taken directly from the National Institutes of Health Clinical Trials site.
You may also view the study information directly on ClinicalTrials.gov